The medical device experts at Advarra can help you navigate the regulatory environment to ensure compliant, high-quality clinical study conduct.
Advarra's experts can work directly with your team to provide consulting and evaluation services related to Good Practices, quality assurance, regulatory compliance, and human research protection for research.
Most requirements for the revised Common Rule, the federal policy for the protection of human subjects in research, went into effect on January 21, 2019. This reference will help you:…
Advarra's customized evaluation and support services for clinical quality assurance (CQA) compliance help ensure your organization maintains appropriate compliance with applicable regulations and good clinical practice (GCP).
With IBC-Ready™, Advarra can help reduce confusion and administrative burden by coordinating with the sponsor, site personnel and local IBC(s) to complete local IBC submission forms.
Advarra’s Canadian review service combines local, expert oversight with streamlined processes and the most extensive site reach in Canada to aid you in the conduct of efficient, responsible research.
Advarra serves as your external support and compliance partner for everything from single investigational sites to multisite research consortia and therapeutic networks.
Advarra provides flexible solutions that help accelerate the initial IRB review process and make it more efficient.
Advarra’s Central Oncology Review service provides robust human subject protections review that cancer research institutions expect.
Advarra's proven technology solutions complement research programs and operational strategies to help clients reach study milestones faster.